Home Newsletters Intestinal Cell News Dysregulation of ILC3s Unleashes Progression and Immunotherapy Resistance in Colon Cancer

Dysregulation of ILC3s Unleashes Progression and Immunotherapy Resistance in Colon Cancer

0
Scientists identified that colorectal cancer manifested with altered ILC3s that were characterized by reduced frequencies, increased plasticity, and an imbalance with T cells.
[Cell]
7992332 {7992332:JCZDHIUR} apa 50 1 165766 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
AbstractGraphical Abstract
Exit mobile version